| Factor Information | |
|---|---|
| Data ID | 1661 |
| Factor | Days in NICU |
| Description | neonatal outcome |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis and diagnosis |
| Objective | Our aim was to evaluate whether brain development in late pregnancy can be predicted by fetal brain Doppler, head biometry and the clinical form of CHD at the time of diagnosis. |
| p Value | <0.01 |
| Conclusion | N/A |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 547 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | AVSD/TOF/TGV/TA/HLHS/AOS/HAA/TA/EA/PS, PA/NA |
| Reference | |
|---|---|
| PMID | 26053596 |
| Year | 2016 |
| Title | Mid-gestation brain Doppler and head biometry in fetuses with congenital heart disease predict abnormal brain development at birth. |
| Sample | ||
|---|---|---|
| Population | Fetuses | |
| Source | CHD fetus | |
| Region | Barcelona, Spain | |
| Method | a prospective cohort study | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | CHD fetuses(Treatment) | control fetuses(Control) |
| Number | 58 | 58 |
| Age | 39.3±1.3 weeks (GA at delivery) | 39.6±1.0 weeks (GA at delivery) |
| Gender (Male: Female) | 37:21 | 29:29 |
| Marker Level | 31±21 days | 0 (0) days |
